Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (Occidental) merosin-positive form
- PMID: 8618689
- DOI: 10.1212/wnl.46.3.815
Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (Occidental) merosin-positive form
Abstract
We studied 50 patients with the merosin-positive form of congenital muscular dystrophy (MP-CMD) clinically and pathologically. The frequency of MP-CMD in our laboratory was approximately one-half that of the Fukuyama type and one-sixth that of Duchenne muscular dystrophy. The early signs of MP-CMD included decreased fetal movement during pregnancy (14%) and poor suck (42%), floppiness (30%), and respiratory difficulty (16%) in early infancy. Eighty-six percent of the patients had delayed motor development. Ninety-two percent of the patients followed beyond age 4 years had learned to walk. The disease was relatively slowly progressive, except in six patients who rapidly lost ambulation. Almost all patients had normal IQ, except four who were mildly to moderately retarded. Of the patients examined by cranial CT/MRI, 24% showed cerebral atrophy and 11% had areas of white matter lucency. Muscle biopsy results in those younger than 5 years showed mild dystrophic changes consisting of variation in fiber size and scattered necrotic and regenerating fibers. In older children, there were additional chronic dystrophic changes, including fiber splitting (32%), moth-eaten appearance (32%), marked fatty replacement (46%), and abnormal fiber type distribution (59%). The manifestations of MP-CMD were generally milder and more slowly progressive than those of the Fukuyama type and merosin-negative form of congenital muscular dystrophy.
Similar articles
-
Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.Neurology. 1996 Mar;46(3):810-14. doi: 10.1212/wnl.46.3.810. Neurology. 1996. PMID: 8618688
-
Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy.Neuromuscul Disord. 2001 May;11(4):350-9. doi: 10.1016/s0960-8966(00)00203-0. Neuromuscul Disord. 2001. PMID: 11369186
-
Congenital muscular dystrophy associated with merosin deficiency.J Child Neurol. 1996 Jul;11(4):291-5. doi: 10.1177/088307389601100406. J Child Neurol. 1996. PMID: 8807418
-
[Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms].Nihon Rinsho. 1997 Dec;55(12):3176-80. Nihon Rinsho. 1997. PMID: 9436431 Review. Japanese.
-
The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.J Med Genet. 2001 Oct;38(10):649-57. doi: 10.1136/jmg.38.10.649. J Med Genet. 2001. PMID: 11584042 Free PMC article. Review.
Cited by
-
A new distal arthrogryposis syndrome characterized by plantar flexion contractures.Am J Med Genet A. 2006 Dec 15;140(24):2797-801. doi: 10.1002/ajmg.a.31528. Am J Med Genet A. 2006. PMID: 17103435 Free PMC article.
-
Diagnostic approach to the congenital muscular dystrophies.Neuromuscul Disord. 2014 Apr;24(4):289-311. doi: 10.1016/j.nmd.2013.12.011. Epub 2014 Jan 9. Neuromuscul Disord. 2014. PMID: 24581957 Free PMC article.
-
Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury.Endocrinology. 2016 Jan;157(1):4-15. doi: 10.1210/en.2015-1443. Epub 2015 Oct 9. Endocrinology. 2016. PMID: 26451739 Free PMC article.
-
Comparison of brain MRI findings with language and motor function in the dystroglycanopathies.Neurology. 2017 Feb 14;88(7):623-629. doi: 10.1212/WNL.0000000000003609. Epub 2017 Jan 13. Neurology. 2017. PMID: 28087826 Free PMC article.
-
Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cells.PLoS One. 2009 Oct 23;4(10):e7563. doi: 10.1371/journal.pone.0007563. PLoS One. 2009. PMID: 19851509 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical